Websites using arrhythmic as a keyword

People who seek relief from an abnormal heart rhythm and physicians who would like to know if catheter ablation is an appropriate treatment for their arrhythmic patients can find answers to their questions on this site.

ADAS 3D: Automatic Detection of Arrhythmic Substrate

Dan's Trust promotes and funds research into the early diagnosis of cardiac risk in the young and the improvement of treatment methods for sudden cardiac arrest...

Tremor and Other Hyperkinetic Movements is an open-access, peer-reviewed scientific journal exclusively devoted to the publication of papers on all tremors and the other hyperkinetic movement disorders. The editor-in-chief is Elan D. Louis, M.D., M.S.

CRY holds ECG screening clinics for those aged 14 to 35 at a number of established locations around the UK including Belfast, Cardiff and London. The CRY mobile screening unit facilitates various screening events at other locations in the UK - often organised by CRY supporters.

Learn more about single-bolus TNKase® (tenecteplase) acute myocardial infarction treatment and the 5-second TNKase® dosing and administration. Indication For use in mortality reduction associated with acute myocardial infarction (AMI). Treatment should be initiated as soon as possible after the onset of AMI symptoms. Important Safety Information TNKase therapy in patients with acute myocardial infarction is contraindicated in the following certain situations (eg, active internal bleeding, history of cerebrovascular accident, known bleeding diathesis, severe uncontrolled hypertension) because of an increased risk of bleeding [See CONTRAINDICATIONS in full prescribing information]. The most common complication encountered during TNKase therapy is bleeding. Should serious bleeding (not controlled by local pressure) occur, any concomitant heparin or antiplatelet agents should be discontinued immediately. In certain conditions (eg, recent major surgery, cerebrovascular disease, hypertension) the risk of TNKase therapy may be increased and should be weighed against the anticipated benefits. [See WARNINGS in full prescribing information]. Cholesterol embolism has been reported rarely in patients treated with all types of thrombolytic agents; the true incidence is unknown. Coronary thrombolysis may result in arrhythmias associated with reperfusion. It is recommended that anti-arrhythmic therapy for bradycardia and/or ventricular irritability be available when TNKase is administered. Please see full Prescribing Information for additional important safety information.

Information for the family and relatives of a young person who has died of a sudden arrhythmic death (SADS)